AI-driven Congruence Therapeutics gets $50M to stabilize misfolded proteins February 8, 2022 Auto Bot Artificial Intelligence, BioPharma, biopharma nl, Drug Discovery, investing, Startups 0 Biotech startup Congruence Therapeutics is developing novel drugs that treat disease by stabilizing misfolded proteins. Key to the company’s approach is a computational platform that discovers and designs these small molecule stabilizers.